Tretinoin
Showing 51 - 75 of 243
Effect of Drug Trial in Taichung (Nivolumab, all trans retinoic acid)
Completed
- Effect of Drug
- Nivolumab
- all trans retinoic acid
-
Taichung, Please Select, TaiwanChina Medical University Hospital
Jul 28, 2022
Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)
Not yet recruiting
- Purpura, Thrombocytopenic, Idiopathic
- all-trans retinoic acid
- Eltrombopag
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jun 25, 2022
Acne Vulgaris Trial in Dresden (Acnatac® Gel left face, Epiduo® Gel right face, Acnatac® Gel right face)
Completed
- Acne Vulgaris
- Acnatac® Gel left face
- +3 more
-
Dresden, Saxony, GermanyUniversitätsklinikum Carl Gustav Carus; Klinik und Poliklinik fü
Oct 22, 2018
Acne Vulgaris Trial in Winston-Salem (clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, tretinoin 0.025%
Completed
- Acne Vulgaris
- clindamycin phosphate 1.2% and tretinoin 0.025%
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences, Dermatology
Aug 9, 2018
Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)
Terminated
- Neuroblastoma
- antibody ch14.18
- +4 more
-
Cologne, GermanyUniversity of Cologne
Nov 3, 2022
Photoaging of Skin, Skin Aging Trial (skin biopsy)
Not yet recruiting
- Photoaging of Skin
- Skin Aging
- skin biopsy
- (no location specified)
May 13, 2023
Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)
Recruiting
- Promyelocytic Leukemia
- Arsenic trioxide
- all-trans retinoic acid
-
Monterrey, Nuevo Leon, MexicoHopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022
Neuroblastoma Trial in Minneapolis (drug, biological, radiation)
Recruiting
- Neuroblastoma
- Carboplatin
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Refractory Mixed Type Melasma Trial in New York (Q-Switched Nd:YAG Laser (RevLite), Retin-A and microdermabrasion)
Completed
- Refractory Mixed Type Melasma
- Q-Switched Nd:YAG Laser (RevLite)
- Retin-A and microdermabrasion
-
New York, New YorkNew York Laser and Skin Care
Jan 5, 2022
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma Trial in Chicago (Fenretinide)
Not yet recruiting
- T-cell Lymphoma
- +10 more
-
Chicago, IllinoisRush University Medical Center
Oct 24, 2022
Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)
Not yet recruiting
- Glioma
- +3 more
- Retifanlimab
- All-trans retinoic acid
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 22, 2022
Acne Vulgaris Trial in Jakarta (Combination cream, Placebo cream)
Recruiting
- Acne Vulgaris
- Combination cream
- Placebo cream
-
Jakarta, DKI Jakarta, IndonesiaRumah Sakit Angkatan Darat Gatot Soebroto
Jan 6, 2022
Keratosis Pilaris Trial in Dayton (Salkera Emollient Foam)
Terminated
- Keratosis Pilaris
- Salkera Emollient Foam
-
Dayton, OhioWright State University School of Medicine, Department of Dermat
Feb 3, 2022
Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)
Recruiting
- Acute Myeloid Leukemia
- All-trans retinoic acid
- +2 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022
Acne Vulgaris Trial in Jakarta (Anti-Acne Preparations for Topical Use)
Completed
- Acne Vulgaris
- Anti-Acne Preparations for Topical Use
-
Jakarta, DKI Jakarta, IndonesiaSMKN 35 Jakarta Barat
May 31, 2020
Immune Thrombocytopenia Trial in Beijing (Dexamethasone, ATRA)
Completed
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 22, 2021
Wrinkle Trial in Chicago (Tixel 2)
Recruiting
- Wrinkle
- Tixel 2
-
Chicago, IllinoisPhysicians Laser & Dermatology Institute, LLC
Mar 7, 2022
Acne Vulgaris Trial in Charlotte (Tretinoin cream, 0.05%, RETIN-A® (tretinoin) cream, 0.05%, Vehicle of the test product)
Completed
- Acne Vulgaris
- Tretinoin cream, 0.05%
- +2 more
-
Charlotte, North CarolinaCatawba Research, LLC
May 16, 2018
Solid Tumor Trial in San Diego (Cabozantinib, 13-cis-retinoic acid)
Recruiting
- Solid Tumor
- Cabozantinib
- 13-cis-retinoic acid
-
San Diego, CaliforniaRady Children's Hospital - San Diego
Oct 6, 2021
Acne Vulgaris Trial in Charlotte (Tretinoin cream 0.1%, RETIN-A® Cream, Vehicle of the test product)
Completed
- Acne Vulgaris
- Tretinoin cream 0.1%
- +2 more
-
Charlotte, North CarolinaCatawba Research, LLC
May 16, 2018
Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in
Completed
- Recurrent Acute Leukemia of Ambiguous Lineage
- +5 more
- Chemosensitivity Assay
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 29, 2022
Multiple Myeloma Trial in Amsterdam (all-trans retinoic acid (ATRA))
Active, not recruiting
- Multiple Myeloma
- all-trans retinoic acid (ATRA)
-
Amsterdam, NH, NetherlandsVU University Medical Center
May 5, 2022
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Self-Management, Behavior, Patient Empowerment Trial in Lausanne (Education)
Not yet recruiting
- Self-Management
- +2 more
- Education
-
Lausanne, VD, SwitzerlandCentre hospitalier universitaire vaudois
Feb 5, 2023